ARC® Press Releases

ARC Fertility Among Thirty Companies Recognized for Achievements During 2nd Annual Health Value Awards

PORTSMOUTH, N.H. (PRWEB) MAY 02, 2019 – Validation Institute, an independent, objective, 3rd party organization focused on changing healthcare, hosted the second annual Health Value Awards Sunday evening at the Marriott Wardman Park Hotel in Washington, D.C. The ceremony recognized more than thirty companies and individuals leading innovative changes in healthcare.


ARC Fertility Releases Key Findings on Fertility Treatments at ASRM Annual Meeting

New studies analyze impacts of national and regional social and economic differences, doctor-patient communication, and digital information on treatment selection and frequency

Saratoga, CA (November 4, 2015) ARC Fertility, a pioneer in innovative fertility treatment options, today announced the findings from new studies on key factors influencing the frequency, selection and success of fertility treatment methods from the American Society for Reproductive Medicine’s ( 2015 Annual Meeting.

“The research we conducted in cooperation with other leading institutions shows a direct correlation between a number of factors on when, where and how women select reproductive treatments,” said Dr. David Adamson, CEO and Chairman of ARC Fertility and co-author of the studies. “We believe these insights can help promote best practices in reproductive health and assist patients and their physicians in making the best choices that provide the most optimal outcomes.”


ARC Fertility Introduces the ARC Telehealth System Mobile Solution

Demand for Telehealth is Increasing

Largest network of fertility specialists in the United States provides technology to enhance communication between fertility patients and medical professionals

Saratoga, CA, October 15, 2015 – ARC® Fertility today announced its Telehealth System, designed to help fertility patients connect with medical professionals via mobile devices to improve communication, speed treatment and increase quality of care. The ARC® Telehealth System allows medical practices specializing in in-vitro fertilization and other fertility treatments additional flexibility to connect with patients, delivering a cost-effective tool for enabling high-quality care while ensuring confidentiality. This solution is HIPAA compliant. In addition, the system features on-screen sharing of important medical information such as test results, e-document signing to ensure compliance, and options to appropriately record essential aspects of the interaction for medical record purposes.


New ARC Fertility Success Program Broadens Portfolio of Affordable IVF Treatment Options


Three-cycle program can nearly double the chance for success while lowering the overall cost to bring home a baby

SARATOGA, Calif., Oct. 5, 2015 /PRNewswire/ — ARC Fertility® ( today announced its new program designed to maximize the chances for having a baby as a result of in vitro fertilization, without increasing the financial burden of a multi-cycle IVF treatment program. The ARC® Success Program [] provides multi-cycle packages with a rebate to the patient upon the birth of a baby. Roughly 48 percent of patients undergoing a single cycle of IVF treatment have a baby, but that success rate grows to 83 percent for patients undergoing three cycles of treatment.

“We know that for women seeking to become pregnant through IVF treatment the two biggest concerns are whether the procedure will result in a live birth and how much it will cost,” said Dr. David Adamson, CEO of ARC Fertility. “Our new ARC Success Program can help relieve those concerns by substantially increasing the opportunity for success through multiple cycles of treatment while containing the overall cost. We are excited to offer this innovative program to our ARC member clinics and their IVF patients.”


Dr. David Adamson, CEO of ARC Fertility Honored by RESOLVE: The National Fertility Organization

Night of Hope

RESOLVE: The National Infertility Association Recognizes Dr. Adamson’s Contributions to the Family Building Community

Saratoga, CA, September 29, 2015 – David Adamson, MD, FRCSC, FACOG, FACS, reproductive endocrinologist, surgeon, medical director of Palo Alto Medical Foundation (PAMF) Fertility Physicians of Northern California, and Chief Executive Officer of ARC® Fertility is being awarded the Barbara Eck Founders Award, RESOLVE’s highest award, for his demonstrated leadership, volunteerism, and research in the field of infertility. Dr. Adamson will accept the award at RESOLVE’s Night of Hope Gala on November 17, 2015 in New York City. As the organization that supports and provides a voice for people diagnosed with infertility, RESOLVE established the Hope Awards to recognize professionals, companies, volunteers, and the media who have demonstrated leadership in the infertility field or have made a positive impact in the lives of people struggling with infertility.


Advanced Reproductive Care: Let’s Get Real About Egg Freezing

Egg Freezing

Popular Fertility Procedure Not A Guarantee For Pregnancy

Saratoga, CA – Egg Freezing is becoming an increasingly popular way for women to try to delay childbearing, but Advanced Reproductive Care Inc. (ARC) [], the largest network of fertility specialists in the United States, is advising women to look at all of the medical evidence and implications before embarking on this procedure, which has a lower success rate than is being promoted by some egg-freezing advocates and cannot guarantee a baby in the future.


Embryo Donation Offers Opportunities for Infertile Couples, but Many Factors Need to be Considered


Embryo donation plays an important role in fertility treatments: Here is what you should know

Saratoga, CA (March 24, 2015) – Embryo donation has become a popular procedure to address infertility, but according to Dr. David Adamson, founder and CEO of ARC Fertility (, the largest network of fertility specialists in the United States, it is critical for patients to consider some difficult issues associated with both donating or receiving donated embryos.


ARC Fertility Supports Preimplantation Genetic Diagnosis (PGD) for Healthier Babies

Saratoga, CA (February 18, 2015) – As reproductive science advances, fertility scientists, embryologists and doctors are constantly developing new techniques to help families have healthy pregnancies and healthy children. One such advancement, preimplantation genetic diagnosis (PGD), is an important addition to successful fertility treatments, and is being supported by ARC Fertility, the largest network of fertility specialists in the county. PGD involves testing a day 5 embryo (blastocyst) for a specific known genetic abnormality, and preimplantation genetic screening (PGS) is screening of a blastocyst to determine if the chromosomes are normal. According to a recently published report, the global preimplantation genetic diagnosis market is estimated to reach $47.4 million by the end of 2018.


Advanced Reproductive Care Urges Couples to Consider Reproductive Future Prior to Chemotherapy Treatments

Patients of All Ages Should Plan and Prepare

Saratoga, CA (January 28, 2015) – When faced with a cancer diagnosis, many patients become overwhelmed with the decisions they must make regarding their cancer treatments, and their reproductive futures often take a backseat. Unfortunately, many patients who are not fully informed about their options learn about the steps needed to insure a reproductive future too late. Advanced Reproductive Care, Inc. (ARC) [], the largest network of fertility specialists in the United States, is advising both men and women to consider their options and educate themselves before cancer treatments, should they plan to have a family.


ARC Advises Men with Fertility Issues to Be Careful With Sunscreen

Certain UV filters absorbed into the skin may affect hormonal processes

Saratoga, CA (January 6, 2015) – Advanced Reproductive Care Inc. (ARC) [], the largest network of fertility specialists in the United States and a pioneer in reproductive medicine, is advising men to moderate their use of sunscreen if they are trying to conceive.

A preliminary study conducted by the National Institutes of Health (NIH) and the Department of Health’s Wadsworth Center in New York reveals that benzophenone (BP) type ultraviolet (UV) filters, which include nearly 30 chemicals that are often found in sunscreens as well as other cosmetic products, may cause male infertility. Researchers discovered that men who were highly exposed to UV filters 4OH-BP or BP-2 had a 30 percent decline in the biological capability of a person to reproduce.